What does the acquisition of AllCells by Discovery Life Sciences mean for my ongoing projects at Discovery and / or AllCells? | Discovery Life Sciences

Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis NEW Blog Post - Progressing Ex Vivo Gene Editing Innovations with High-Quality Leukopaks NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments NEW Video - Advancing Oligo Therapeutics: Gene Knockdown Studies in Human Hepatocytes

Learn More about Discovery's AI-Annotated FFPE Tissues and DiscoverAI Tissue Analysis NEW Blog Post - Progressing Ex Vivo Gene Editing Innovations with High-Quality Leukopaks NEW Blog Post - Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments NEW Video - Advancing Oligo Therapeutics: Gene Knockdown Studies in Human Hepatocytes

AllCells’ scientists will remain part of Discovery, and all ongoing studies will continue to be serviced by those same dedicated experts. The flow of projects and timelines will be unaffected by the acquisition.

Privacy Settings